Endothelium-derived relaxing factor (EDRF) is a recently discovered paracrine hormone released from the endothelium lining the vasculature. EDRF is released in vivo by a number of factors including bradykinin, acetylcholine and shear stress. EDRF has been shown to cause diuresis and natriuresis without a change in glomerular filtration rate. These data could be explained by either a pressure diuresis or an direct inhibition of tubular transport caused by EDRF. A direct inhibition of sodium and water absorption by EDRF in individual nephron segments has not been reported to date. Our hypothesis is that EDRF produced by renal endothelial cells inhibits fluid and sodium transport in the collecting duct system. This is based on 1) our preliminary data showing that EDRF inhibits transport in cultured collecting duct cells; 2) the proximity of the renal vessels and nephrons; and 3) the fact that EDRF stimulates cGMP production in vascular tissue, while cGMP inhibits transport in the collecting duct.
Our specific aims are to investigate: 1) the effects of EDRF on basal sodium and water transport; 2) the effects of EDRF on vasopressin-stimulated transport of sodium and water; 3) whether the second messenger cascade of EDRF involves activation of soluble guanylate cyclase and consequent increase of cGMP; 4) the roles of cGMP-dependent protein kinase and phosphodiesterase in mediating the effects of EDRF; and 5) whether the sodium channel is phosphorylated as part of the response to EDRF. We will use a variety of techniques to address these specific aims.
In aims #1 and #2 we will measure transepithelial sodium and water flux.
In aim #3 we will assay cyclic nucleotides and measure soluble and particulate guanylate cyclase activity.
In aim #4 we will measure kinases and phosphodiesterases.
In aim #5 we will immunoprecipitate the amiloride-sensitive sodium channel and use Western blot analysis to determine whether a subunit of the channel is phosphorylated. The collecting duct system plays a pivotal role in the fine regulation of solute and water excretion, and consequently extracellular fluid volume. Extracellular fluid volume is one of the primary determinants of blood pressure. There are few data concerning the effects of EDRF on transport along the nephron, and yet it may prove to be one of the most important regulators of collecting duct sodium and water absorption.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL028982-20
Application #
6495727
Study Section
Project Start
2001-09-01
Project End
2002-08-31
Budget Start
Budget End
Support Year
20
Fiscal Year
2001
Total Cost
$73,467
Indirect Cost
Name
Henry Ford Health System
Department
Type
DUNS #
073134603
City
Detroit
State
MI
Country
United States
Zip Code
48202
Kumar, Nitin; Liao, Tang-Dong; Romero, Cesar A et al. (2018) Thymosin ?4 Deficiency Exacerbates Renal and Cardiac Injury in Angiotensin-II-Induced Hypertension. Hypertension 71:1133-1142
Bryson, Timothy D; Gu, Xiaosong; Khalil, Remonda M et al. (2018) Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction. J Mol Cell Cardiol 118:1-12
Cerniello, Flavia M; Carretero, Oscar A; Longo Carbajosa, Nadia A et al. (2017) MAS1 Receptor Trafficking Involves ERK1/2 Activation Through a ?-Arrestin2-Dependent Pathway. Hypertension 70:982-989
Ramseyer, Vanesa D; Ortiz, Pablo A; Carretero, Oscar A et al. (2016) Angiotensin II-mediated hypertension impairs nitric oxide-induced NKCC2 inhibition in thick ascending limbs. Am J Physiol Renal Physiol 310:F748-F754
González, Germán E; Rhaleb, N-E; D'Ambrosio, Martin A et al. (2016) Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 311:H1287-H1296
Gu, Xiaosong; Xu, Jiang; Zhu, Liping et al. (2016) Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor. Circ Heart Fail 9:
Kumar, Nitin; Nakagawa, Pablo; Janic, Branislava et al. (2016) The anti-inflammatory peptide Ac-SDKP is released from thymosin-?4 by renal meprin-? and prolyl oligopeptidase. Am J Physiol Renal Physiol 310:F1026-34
Zhu, Liping; Yang, Xiao-Ping; Janic, Branislava et al. (2016) Ac-SDKP suppresses TNF-?-induced ICAM-1 expression in endothelial cells via inhibition of I?B kinase and NF-?B activation. Am J Physiol Heart Circ Physiol 310:H1176-83
Saez, Fara; Hong, Nancy J; Garvin, Jeffrey L (2016) Luminal flow induces NADPH oxidase 4 translocation to the nuclei of thick ascending limbs. Physiol Rep 4:
Cerrato, Bruno D; Carretero, Oscar A; Janic, Brana et al. (2016) Heteromerization Between the Bradykinin B2 Receptor and the Angiotensin-(1-7) Mas Receptor: Functional Consequences. Hypertension 68:1039-48

Showing the most recent 10 out of 381 publications